Medtronic plc develops, manufactures, and sells medical devices and therapies to healthcare providers and patients globally. Its revenue is derived from several segments: Cardiovascular Portfolio (approximately 40%), Medical Surgical Portfolio (around 30%), Neuroscience Portfolio (about 20%), and Diabetes Operating Unit (approximately 10%). The company offers a wide range of products, including cardiac devices, surgical instruments, and diabetes management systems. Factors supporting its endurance include a strong product pipeline and established relationships with healthcare systems, while potential limitations include regulatory challenges and competition from other medical device manufacturers.
—
Medtronic plc develops, manufactures, and sells medical devices and therapies to healthcare providers and patients globally. Its revenue is derived from several segments: Cardiovascular Portfolio (approximately 40%), Medical Surgical Portfolio (around 30%), Neuroscience Portfolio (about 20%), and Diabetes Operating Unit (approximately 10%). The company offers a wide range of products, including cardiac devices, surgical instruments, and diabetes management systems. Factors supporting its endurance include a strong product pipeline and established relationships with healthcare systems, while potential limitations include regulatory challenges and competition from other medical device manufacturers.
—
Daily adjusted close
Medtronic plc develops, manufactures, and sells medical devices and therapies to healthcare providers and patients globally. Its revenue is derived from several segments: Cardiovascular Portfolio (approximately 40%), Medical Surgical Portfolio (around 30%), Neuroscience Portfolio (about 20%), and Diabetes Operating Unit (approximately 10%). The company offers a wide range of products, including cardiac devices, surgical instruments, and diabetes management systems. Factors supporting its endurance include a strong product pipeline and established relationships with healthcare systems, while potential limitations include regulatory challenges and competition from other medical device manufacturers.